Optimization of the treatment's results mostly consists in the surgical technique improvement. In this study, the effect of follicle-stimulating hormone (FSH) therapy on the viability of micro-anastomoses after the reconstruction of the seminal paths was studied.
INTRODUCTION AND OBJECTIVES: Microscopic testicular sperm extraction (mTESE) represents a viable option for sperm retrieval in men with nonobstructive azoospermia (NOA), and histopathology is the only known variable that consistently predicts surgical sperm retrieval rate (SRR). We examined our institutional experience with mTESE sperm retrieval rates and performed multivariable regression to develop a predictive nomogram for successful sperm retrieval.
METHODS: A retrospective chart review was performed for all patients undergoing mTESE at our institution from 2012 to 2018. Patient demographics, preoperative laboratory workup, semen analysis, operative findings, pathology, and success rates were reviewed. Only patients with NOA were included in the final analysis. Univariate analysis was performed using chi-square for categorical variables and t-tests for continuous variables. A multivariable logistic regression was then fitted and backward variable selection performed based upon concordance index. The final model was internally validated via bootstrapping and calibration of the prediction model was visually confirmed.
RESULTS: Between 2012 and 2018, 118 patients underwent a total of 129 mTESE procedures with an overall SRR of 57%. 95 patients with NOA of varying etiologies were included in the final analysis. Semen pH ranged from 6.8 to 8. Final pathology demonstrated Sertoli only pattern in 57%, maturation arrest in 14%, hypospermatogenesis in 19%, and mixed or unavailable pathology in 11% of patients. Univariate analysis demonstrated an association between semen pH and successful sperm retrieval (p[0.035). Multivariable logistic regression identified semen volume, semen pH, and FSH as predictors of success, and a nomogram (Figure 1 ) was produced with a concordance index of 0.68.
CONCLUSIONS: We generated a predictive nomogram based upon preoperative semen volume, pH, and FSH as variables associated with successful mTESE. While the mechanism by which volume and pH may predict SRR is unclear, this model may provide modest benefit when counseling patients regarding individualized success rates prior to undergoing mTESE. is an effective treatment for hypogonadism, recent concerns regarding its safety have been raised. In 2015, the US Food and Drug Administration issued a warning about potential cardiovascular risks resulting from TRT. Fertility preservation is another potential concern especially for men in reproductive age. We aim to assess the effect of Selective Estrogen Receptor Modulator (SERM), Aromatase Inhibitor (AI) and human Chorionic Gonadotrophin (hCG) on Total Testosterone levels (TT), hypogonadism and erectile function via meta-analysis METHODS: We performed a systematic literature review from 1987e2018 via PubMed, Cochrane review and Web of Science. Subject terms used were infertility, hypogonadism, alternative to testosterone therapy, Selective Estrogen Receptor Modulator, Aromatase Inhibitor and human Chorionic Gonadotrophin. Studies which reported an effect of TT and hypogonadism following treatment of each medication were selected. Hypogonadal symptoms assessed by the androgen deficiency of the aging male (ADAM) questionnaire was included. Aggregated data was analyzed via Chi-Squared Analysis.
RESULTS: From the available literature, 25 studies were selected, of which 12 studies evaluated efficacy of AIs, 8 evaluated SERMs, and 5 evaluated hCG effects. For SERMs, 512 patients with mean age 42.3AE1.94 years showed mean TT pre-treatment vs posttreatment (167.9AE202.8 vs 366.2AE32.3, Copyright © 2019 American Urological Association Education and Research, Inc. Unauthorized reproduction of this article is prohibited.
